1. What happens after stopping Wegovy or Zepbound?
Withdrawal trials show that substantial weight regain is common after semaglutide or tirzepatide is stopped. The evidence supports planning maintenance before treatment ends rather than assuming the goal weight marks the end of care.
Full article: https://belite.com/what-happens-after-stopping-wegovy-zepbound/
2. How much muscle is lost on GLP-1 treatment?
Most lost weight is fat, but some lean mass usually declines. Protein intake, resistance training, adequate nutrition, and functional monitoring deserve particular attention in older adults and patients losing weight rapidly.
Full article: https://belite.com/glp-1-muscle-loss-lean-mass-protein-strength-training/
3. Zepbound vs. Wegovy
The direct SURMOUNT-5 comparison found greater average weight loss with tirzepatide than semaglutide. The best individual treatment still depends on tolerability, indication, access, and the ability to continue therapy.
Full article: https://belite.com/zepbound-vs-wegovy-head-to-head-trial/
4. FDA psychiatric-safety update
FDA found no increased risk of suicidal thoughts or behavior with GLP-1 receptor agonists and requested removal of warning language from selected labels. New mood symptoms still require prompt evaluation.
Full article: https://belite.com/fda-removes-glp-1-suicidal-thoughts-warning/
5. Survodutide Phase 3
A large Phase 3 trial confirms substantial weight-loss efficacy for the investigational dual glucagon/GLP-1 agonist. It remains unapproved and should not be purchased as a research peptide.
Full article: https://belite.com/survodutide-phase-3-weight-loss-trial/
Clinical Pearl of the Week
The maintenance phase begins before goal weight. A patient and clinician should define the plan for dose, monitoring, nutrition, physical activity, and access before treatment is interrupted. |
Myth vs. Fact
Myth: If weight returns after a GLP-1 medication is stopped, the patient failed.
Fact: Withdrawal studies show that appetite and metabolic biology commonly re-emerge. Regain is a treatment-planning issue, not a moral judgment.
Questions we are watching
- Can lower-dose or extended-interval maintenance preserve most of the benefit?
- Which strategies best protect muscle and function in older adults?
- Which patients benefit most from GLP-1, GIP/GLP-1, or glucagon/GLP-1 approaches?
- How should medication be restarted safely after prolonged interruption?
- Which emerging medications will demonstrate cardiovascular benefit rather than weight loss alone?
About BeLite Medical Center
BeLite Medical Center in Northern, VA helps you reach your weight loss goals.
